Major Depressive Disorder
Showing NaN - NaN of 155
MDD Trial in New York (Siemens 7T MRI, Sham Neurofeedback)
Recruiting
- Major Depressive Disorder
- Siemens 7T MRI
- Sham Neurofeedback
-
New York, New YorkIcahn School Of Medicine at Mount Sinai
Jul 5, 2023
Depression, Suicidal Ideation, MDD Trial in New York ("Engage & Connect" Psychotherapy, Symptom Review and Psychoeducation
Not yet recruiting
- Depression
- +3 more
- "Engage & Connect" Psychotherapy
- Symptom Review and Psychoeducation (SRP)
-
New York, New YorkWeill Cornell Medicine
Jun 28, 2023
MDD, Apathy Trial in New York, White Plains (Targeted Cognitive Training Intervention, General Cognitive Training Intervention)
Not yet recruiting
- Major Depressive Disorder
- Apathy
- Targeted Cognitive Training Intervention
- General Cognitive Training Intervention
-
New York, New York
- +1 more
May 17, 2023
MDD Trial in United States (Lumateperone, Placebo)
Recruiting
- Major Depressive Disorder
- Lumateperone
- Placebo
-
Pico Rivera, California
- +17 more
May 9, 2023
MDD, Treatment Resistant Depression Trial in New York (Medtronic Percept PC DBS system)
Recruiting
- Major Depressive Disorder
- Treatment Resistant Depression
- Medtronic Percept PC DBS system
-
New York, New YorkIcahn School of Medicine at Mount Sinai, Mount Sinai West
Mar 6, 2023
MDD Trial in New York (Empagliflozin)
Not yet recruiting
- Major Depressive Disorder
-
New York, New YorkNYU Langone Health
Feb 24, 2023
Alzheimer, MDD Trial in New York, Orangeburg (Escitalopram Oxalate, Placebo)
Recruiting
- Alzheimer Disease
- Major Depressive Disorder
- Escitalopram Oxalate
- Placebo
-
New York, New York
- +1 more
Dec 29, 2022
MDD Trial in Boston, New York (Transcranial Photobiomodulator, Sham)
Not yet recruiting
- Major Depressive Disorder
- Transcranial Photobiomodulator
- Sham
-
Boston, Massachusetts
- +3 more
Dec 7, 2022
MDD Trial in New York (SEP-363856, Placebo)
Recruiting
- Major Depressive Disorder
- SEP-363856
- Placebo
-
New York, New YorkFor additional information regarding sites, contact 844-687-8522
Nov 14, 2022
MDD Trial in New York (Fisher Wallace Cranial Electrotherapy Stimulator (Active Device), Fisher Wallace Cranial Electrotherapy
Completed
- Major Depressive Disorder
- Fisher Wallace Cranial Electrotherapy Stimulator (Active Device)
- Fisher Wallace Cranial Electrotherapy Stimulator (Placebo Device)
-
New York, New YorkNew York Neuromodulation Medical, PLLC
Nov 3, 2022
MDD, Insomnia Trial in United States (SAGE-217, Placebo)
Terminated
- Major Depressive Disorder
- Insomnia
- SAGE-217
- Placebo
-
Little Rock, Arkansas
- +27 more
Oct 13, 2022
MDD, Generalized Anxiety Disorder Trial in New York (HPDT-DA-013)
Recruiting
- Major Depressive Disorder
- Generalized Anxiety Disorder
- HPDT-DA-013
-
New York, New YorkHappify Health (Remote)
Aug 5, 2022
Suicidal Ideation, MDD Trial in New York (Belbuca Buccal Product, Placebo)
Recruiting
- Suicidal Ideation
- Major Depressive Disorder
- Belbuca Buccal Product
- Placebo
-
New York, New YorkNew York State Psychiatric Institute
Jul 30, 2022
MDD Trial in United States (XEN1101 10 mg, XEN1101 20 mg, Placebo)
Recruiting
- Major Depressive Disorder
- XEN1101 10 mg
- +2 more
-
Lafayette, California
- +5 more
Jul 11, 2022
Treatment Resistant Depression, MDD Trial in New York (Repetitive Transcranial Magnetic Stimulation)
Recruiting
- Treatment Resistant Depression
- Major Depressive Disorder
- Repetitive Transcranial Magnetic Stimulation
-
New York, New YorkWeill Cornell Medicine
Jun 24, 2022
MDD Trial in New York (Cognitive Behavior Therapy (CBT), Nonspecific Supportive Therapy (PBO))
Recruiting
- Major Depressive Disorder
- Cognitive Behavior Therapy (CBT)
- Nonspecific Supportive Therapy (PBO)
-
New York, New YorkNew York State Psychiatric Institute
Jun 22, 2022
MDD Trial in New York (Ketamine)
Completed
- Major Depressive Disorder
-
New York, New YorkNew York State Psychiatric Institute/Columbia University
May 31, 2022
MDD Trial in New York ("Engage & Connect" Psychotherapy, Symptom Review and Psychoeducation (SRP))
Recruiting
- Major Depressive Disorder
- "Engage & Connect" Psychotherapy
- Symptom Review and Psychoeducation (SRP)
-
New York, New YorkWeill Cornell Medicine
May 23, 2022
MDD Trial in United States (SP-624, Placebo)
Active, not recruiting
- Major Depressive Disorder
- SP-624
- Placebo
-
Phoenix, Arizona
- +38 more
May 13, 2022
Post Traumatic Stress Disorder, MDD Trial in New York (Escitalopram, Duloxetine)
Terminated
- Post Traumatic Stress Disorder
- Major Depressive Disorder
-
New York, New YorkNew York State Psychiatric Institute
Apr 12, 2022